Immunosuppression and the prognosis of patients suffering from myeloproliferative disorders after liver transplantation

Transplant Proc. 2002 Aug;34(5):1493-4. doi: 10.1016/s0041-1345(02)02943-3.

Authors

Matthias J Bahr¹, J Rosenau, U J F Tietge, M Caselitz, M W Hofmann, J Klempnauer, K H W Böker, C P Strassburg, M P Manns

Affiliation

¹ Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Hannover, Carl-Neuberg-Strasse 1, 30623 Hannover, Germany. matthias.bahr@gmx.de

PMID: 12176453
DOI: 10.1016/s0041-1345(02)02943-3

No abstract available

MeSH terms

Adult
Budd-Chiari Syndrome / surgery
Female
Follow-Up Studies
Germany
Humans
Immunosuppression Therapy / methods*
Liver Transplantation / immunology*
Male
Myeloproliferative Disorders / epidemiology*
Postoperative Complications / epidemiology*
Prognosis
Retrospective Studies
Time Factors